[Treatment and monitoring of patients with signs of premature labor up to the 32d week of pregnancy].
D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D001424:Bacterial Infections / Q000517:prevention & control; D002821:Chorioamnionitis / Q000517:prevention & control; D005260:Female; D005317:Fetal Growth Retardation / Q000175:diagnosis; D005323:Fetal Monitoring; D005325:Fetal Organ Maturity / Q000187:drug effects; D006801:Humans; D008168:Lung / Q000196:embryology; D008431:Maternal-Fetal Exchange / Q000187:drug effects; D007752:Obstetric Labor, Premature / Q000175:diagnosis / Q000517:prevention & control*; D011247:Pregnancy; D014590:Uterine Contraction / Q000187:drug effects; D014592:Uterine Hemorrhage / Q000517:prevention & control
D000318:Adrenergic beta-Agonists
Die Behandlung und Uberwachung von Patienten mit Frühgeburtszeichen bis zur 32. Woche der Schwangerschaft.